Profile

New User

New to Graphy Publications? Create an account to get started today.

Registered Users

Have an account? Sign in now.

How to Cite | Author Information | Publication History
International Journal of Clinical Nutrition & Dietetics Volume 6 (2020), Article ID 6: IJCND-152, 8 pages
https://doi.org/10.15344/2456-8171/2020/152
Research Article
Effects of Pine Bark Extract on Attention-deficit Hyperactivity Disorder in Adults: A Randomized Double-blind Crossover Study

Cheng-Dien Hsu1, Li-Hsuan Hsieh2, Ya-Ling Chen2, I-Cheng Lin3, Ying-Ru Chen3, Chih-Chi Chen3 and Suh-Ching Yang2,4,5*

1Department of Psychiatry, Taiwan Adventist Hospital, Taipei 10556, Taiwan
2School of Nutrition and Health Sciences, Taipei Medical University, Taipei 11031, Taiwan
3Department of Psychiatry, Hsuang Ho Hospital, New Taipei City 23455, Taiwan
4Research Center of Geriatric Nutrition, College of Nutrition, Taipei Medical University, Taipei 11031, Taiwan
5Nutrition Research Center, Taipei Medical University Hospital, Taipei 11031, Taiwan
Dr Suh-Ching Yang, School of Nutrition and Health Sciences, Taipei Medical University, 250 Wu-Hsing Street, Taipei 11031, Taiwan. Tel: +886-2-2736-1661, Fax: +886-2-2737-3112; E-mail: sokei@tmu.edu.tw
08 May 2020; 24 June 2020; 26 June 2020
Hsu CD, Hsieh LH, Chen YL, Lin IC, Chen YR, et al. (2020) Effects of Pine Bark Extract on Attention-deficit Hyperactivity Disorder in Adults: A Randomized Double-blind Crossover Study. Int J Clin Nutr Diet 6: 152. doi: https://doi.org/10.15344/2456-8171/2020/152
© 2020 Hsu et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

References

  1. Rowland AS, Lesesne CA, Abramowitz AJ (2002) The epidemiology of attention-deficit/hyperactivity disorder (ADHD): a public health view. Ment Retard Dev Disabil Res Rev 8: 162-170. View
  2. Fayyad J, Sampson NA, Hwang I, Adamowski T, Gaxiola SA, et al. (2017) The descriptive epidemiology of DSM-IV Adult ADHD in the World Health Organization World Mental Health Surveys. Atten Defic Hyperact Disord 9: 47-65. View
  3. Huang CLC, Chu CC, Cheng TJ, Weng SF (2014) Epidemiology of treated attention-deficit/hyperactivity disorder (ADHD) across the lifespan in Taiwan: a nationwide population-based longitudinal study. PloS one 9: e95014. View
  4. Barkley RA, Fischer M, Smallish L, Fletcher K (2002) The persistence of attention-deficit/hyperactivity disorder into young adulthood as a function of reporting source and definition of disorder. J Abnorm Psychol 111: 279- 289. View
  5. Wilens TE, Biederman J, Spencer TJ (2002) Attention deficit/hyperactivity disorder across lifespan. Annu Rev Med 53: 113131. View
  6. Joseph N, Zhang-James Y, Perl A, Faraone SV (2015) Oxidative stress and ADHD: a meta-analysis. J Atten Disord 19: 915-924. View
  7. Segal L, Penman M, Piriou Y (2018) Evaluation of the systemic toxicity and mutagenicity of OLIGOPIN®, procyanidolic oligomers (OPC) extracted from French Maritime Pine Bark extract. Toxicol Rep 5: 531-541. View
  8. Heimann SW (1999) Pycnogenol for ADHD? J Am Acad ChildAdolesc Psychiatry 38: 357-358. View
  9. Chen YR, Su YJ, Piriou Y, Yang SC (2017) Effects of polyphenolic extract from pine bark on the improvement of attention deficit/hyperactivity disorder in children and adolescent. Int J Clin Nutr Diet 3: 116-119. View
  10. Chovanová Z, Muchová J, Sivoňová M, Dvořáková M, Žitňanová I, et al. (2006) Effect of polyphenolic extract, Pycnogenol®, on the level of 8-oxoguanine in children suffering from attention deficit/hyperactivity disorder. Free Radic Res 40: 1003-1010. View
  11. Trebatická J, Kopasová S, Hradečná Z, Činovský K, Škodáček I, et al. (2006) Treatment of ADHD with French maritime pine bark extract, Pycnogenol®. Eur Child Adolesc Psychiatry 15: 329-35. View
  12. Dvořáková M, Ježová D, Blažíček P, Trebatická J, Škodáček I, et al. (2007) Urinary catecholamines in children with attention deficit hyperactivity disorder (ADHD): modulation by a polyphenolic extract from pine bark (Pycnogenol®). Nutr Neurosci 10: 151-157. View
  13. Kessler RC, Adler L, Ames M, Demler O, Faraone S, et al. (2005) The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population. Psychol Med 35: 245-256. View
  14. Conners KC, Staff M (2015) CPT III: Conners' Continuous Performance Test III: Multi-Health Systems North Tonawanda, New York, NY, US.
  15. Wechsler D (1997) WMS-III: Wechsler memory scale administration and scoring manual: Psychological Corporation, New York, NY, US.
  16. Tulsky DS, Chiaravalloti ND, Palmer BW, Chelune GJ (2003) The Wechsler Memory Scale, Third Edition: A new perspective. In Clinical interpretation of the WAIS-III and WMS-III. Academic Press, Cambridge, MA, US. View
  17. Heaton RK, Chelune GJ, TalleyJL, Kay GG, Curtiss G, et al. (1993) Wisconsin Card Sorting Test Manual: Revised and Expanded. Psychological Assessment Resources, Odessa, FL, UA. View
  18. Griffith OW (1980) Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal Biochem 106: 207- 212. View
  19. Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95: 351-358. View
  20. Reilly MP, Barry P, Lawson JA, Fitz Gerald G (1997) Urinary 8-epi PGF2α: An index of oxidant stress in vivo. Fibrinolysis Proteol 11: 81-84. View
  21. Segal L, Penman M, Piriou Y (2018) Evaluation of the systemic toxicity and mutagenicity of OLIGOPIN®, procyanidolic oligomers (OPC) extracted from French Maritime Pine Bark extract. Toxicol Rep 5: 531-541. View
  22. Hall CL, Valentine AZ, Groom MJ, Walker GM, Sayal K, et al. (2016) The clinical utility of the continuous performance test and objective measures of activity for diagnosing and monitoring ADHD in children: a systematic review. Eur Child Adolesc Psychiatry 25: 677-699. View
  23. Tenenbaum S, Paull JC, Sparrow EP, Dodd DK, Green L, et al. (2002) An experimental comparison of Pycnogenol and methylphenidate in adults with Attention-Deficit/Hyperactivity Disorder (ADHD). J Atten Disord 6: 49- 60. View
  24. Trebatická J, Ďuračková Z (2015) Psychiatric disorders and polyphenols: can they be helpful in therapy? Oxid Med Cell Longev 2015: 248529. View
  25. Rucklidge JJ, Johnstone J, Kaplan BJ (2009) Nutrient supplementation approaches in the treatment of ADHD. Expert Rev Neurother9: 461-476. View
  26. Millichap JG, Yee MM (2012) The diet factor in attention-deficit/ hyperactivitydisorder. Pediatrics 129: 330-337. View
  27. Del-Ponte B, Callo G, Cruz S, Grellert M, Santos IS, et al. (2019) Dietary patterns and attention deficit/hyperactivity disorder (ADHD): A systematic review and meta-analysis. J Affect Disord 252: 160-173. View
  28. McCann D, Barrett A, Cooper A, Crumpler D, Dalen L, et al. (2007) Food additives and hyperactive behaviour in 3-year-old and 8/9-year-old children in the community: a randomised, double-blinded, placebo-controlled trial. Lancet 370: 1560-1567. View
  29. Takeda A (2001) Zinc homeostasis and functions of zinc in the brain. Bio Metals 14: 343-351. View
Best viewed in Mozilla Firefox, Google Chrome, Safari, Above IE 9.0 version
Privacy Policy | Copyright & Permissions
Copyright © 2013-2024 Graphy Publications, All Rights Reserved.